Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Aba Chemicals Nantong Limited currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This prosecution matter is assigned to 1 distinct examiner, ROMERO, KRISTEN WANG, who represents the only individual currently reviewing the company's applications. The involvement of 1 distinct art unit suggests a highly concentrated technical focus for these efforts. This structure means that the company is not currently navigating multiple sets of examiner preferences or departmental guidelines.
Because the busiest examiner, ROMERO, KRISTEN WANG, is responsible for 1 pending office action, the portfolio's success is tied to a single point of review. This distribution of 1 action to the busiest examiner out of the total workload indicates a lack of diversification across the Biotechnology & Pharmaceuticals sector. Practitioners should note that the 1 distinct art unit assigned to the case provides a singular departmental framework for the company's current intellectual property development. Such a focused profile allows for a specific prosecution strategy but lacks the risk mitigation provided by a broader distribution of cases.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROMERO, KRISTEN WANG | 1 | 69.8% | +30.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18867029 | METHOD FOR PREPARING CARONIC ANHYDRIDE | ROMERO, KRISTEN WANG | — |
| Art Unit | Apps |
|---|---|
| 1624 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18867029 | METHOD FOR PREPARING CARONIC ANHYDRIDE | ROMERO, KRISTEN WANG | 1624 | §103§112DP | Non-Final OA | — | Pending | Nov 19, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAba Chemicals Nantong Limited has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Kristen Wang Romero has the most, with 1 of Aba Chemicals Nantong Limited's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.